These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
392 related items for PubMed ID: 14632812
1. A double-blind, randomized, comparative study of Dysport vs. Botox in primary palmar hyperhidrosis. Simonetta Moreau M, Cauhepe C, Magues JP, Senard JM. Br J Dermatol; 2003 Nov; 149(5):1041-5. PubMed ID: 14632812 [Abstract] [Full Text] [Related]
2. Efficacy of Onabotulinum Toxin A (Botox) versus Abobotulinum Toxin A (Dysport) Using a Conversion Factor (1 : 2.5) in Treatment of Primary Palmar Hyperhidrosis. El Kahky HM, Diab HM, Aly DG, Farag NM. Dermatol Res Pract; 2013 Nov; 2013():686329. PubMed ID: 24250334 [Abstract] [Full Text] [Related]
3. A double-blind, randomized, comparative study of two type A botulinum toxins in the treatment of primary axillary hyperhidrosis. Talarico-Filho S, Mendonça DO Nascimento M, Sperandeo DE Macedo F, DE Sanctis Pecora C. Dermatol Surg; 2007 Jan; 33(1 Spec No.):S44-50. PubMed ID: 17241414 [Abstract] [Full Text] [Related]
4. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature. Vergilis-Kalner IJ. J Drugs Dermatol; 2011 Sep; 10(9):1013-5. PubMed ID: 22052270 [Abstract] [Full Text] [Related]
5. Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients. Schnider P, Moraru E, Kittler H, Binder M, Kranz G, Voller B, Auff E. Br J Dermatol; 2001 Aug; 145(2):289-93. PubMed ID: 11531794 [Abstract] [Full Text] [Related]
6. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study. Vadoud-Seyedi J, Simonart T. Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630 [Abstract] [Full Text] [Related]
7. Botulinum toxin type A in primary palmar hyperhidrosis: randomized, single-blind, two-dose study. Saadia D, Voustianiouk A, Wang AK, Kaufmann H. Neurology; 2001 Dec 11; 57(11):2095-9. PubMed ID: 11739832 [Abstract] [Full Text] [Related]
8. Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms. Schnider P, Binder M, Auff E, Kittler H, Berger T, Wolff K. Br J Dermatol; 1997 Apr 11; 136(4):548-52. PubMed ID: 9155956 [Abstract] [Full Text] [Related]
17. Fractional CO2 laser-assisted Botulinum toxin type A delivery for the treatment of primary palmar hyperhidrosis. Junsuwan N, Manuskiatti W, Phothong W, Wanitphakdeedecha R. Lasers Med Sci; 2021 Feb 11; 36(1):233-236. PubMed ID: 32557001 [Abstract] [Full Text] [Related]
18. [Efficacy of botulinum toxin A in the treatment of axillary and palmar hyperhidrosis: 10 cases]. Maillard H, Briand N, Bara C, Celerier P. Ann Dermatol Venereol; 2003 May 11; 130(5):511-3. PubMed ID: 12843826 [Abstract] [Full Text] [Related]
19. Botulinum A neurotoxin for axillary hyperhidrosis. No sweat Botox. Glogau RG. Dermatol Surg; 1998 Aug 11; 24(8):817-9. PubMed ID: 9723044 [Abstract] [Full Text] [Related]
20. Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia. Chapman MA, Barron R, Tanis DC, Gill CE, Charles PD. Clin Ther; 2007 Jul 11; 29(7):1325-37. PubMed ID: 17825685 [Abstract] [Full Text] [Related] Page: [Next] [New Search]